Sativarg Posted February 15, 2008 Author Share Posted February 15, 2008 GelVac Nasal Powder H5N1 (Bird Flu) Influenza Vaccine Passes Preclinical Toxicology Studies(posted on 15/01/2008) * Key Step Towards Practical Pandemic Preparedness * Conducted To FDA-Reviewed Protocol * Clears Process For Phase I Clinical Later In Year * Influenza Antigen Used Was Non-Egg-Based * True Powder Formulation Using GelSite® Polymer Link to comment Share on other sites More sharing options...
Sativarg Posted February 19, 2008 Author Share Posted February 19, 2008 A New Era in Targeted Anti-Viral TherapeuticsOne of the most exciting technologies to come along in recent times is that of nanotechnology. According to Wikipedia, the online encyclopedia, nanotechnology actually encompasses diverse lines of inquiry. Nanotechnology cuts across many disciplines, including colloidal science, chemistry, applied physics, biology. It could variously be seen as an extension of existing sciences into the nanoscale, or as a recasting of existing sciences using a newer, more modern term. NanoViricides, Inc. is working in the general field of Nanomedicine. This too is a very diverse field and encompasses a wide range of materials and applications. Specifically, we are working in the area of targeted anti-viral therapeutics. Utilizing nanoscale materials and processes licensed from TheraCour Pharma, Inc., we are developing anti-viral drugs against a wide range range of human and animal viruses. NanoViricides, Inc. is a nano-biopharmaceutical company whose business goals are to discover, develop and commercialize therapeutics (nanoviricides™) to advance the care of patients suffering from life-threatening viral infections. We are a development stage company. Link to comment Share on other sites More sharing options...
Recommended Posts
Archived
This topic is now archived and is closed to further replies.